Antibody Services Market Size to Reach USD 3.30 Billion in 2028 Growing at a CAGR of 11.1%, according to Emergen Research

Emergen Research has published its latest report titled “Antibody Services Market By Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling), By Type (Monoclonal, Polyclonal), By End-Use (Bioscience Companies, Bioscience Research Institutions, Hospitals, Others), and By Regions Forecast to 2028”

According to Emergen Research, the global antibody services market size was USD 1.41 Billion in 2020 and is expected to reach USD 3.30 Billion in 2028 and register a revenue CAGR of 11.1% during the forecast period, 2021-2028.

Market Dynamics:

Antibodies can be used to quantify, detect, deliver cargo (such as tiny medicines) and activate specific protein interactions. Bioscientists rely on research-grade antibodies as basic detection tools. Antibodies can be used to mark and identify certain proteins present within a diseased cell at a specific stage of its life cycle, for example, by a researcher seeking to figure out why a cell function has gone wrong. Therefore, the demand for biological products such as antibodies is high in pharmaceutical, biologics and academic research, which drives market revenue growth over the forecast period. Further, antibodies play a crucial role in the immune system's response to a viral infection, measurement of hormones and identification of allergies. 

In addition, rising prevalence of infectious diseases, and rising adoption of targeted immunotherapy and growing number of research institutes and clinical trials, are some major factors surge demand for antibodies in the market. Large pharmaceutical corporations have also shifted their focus to biopharma due to biologics' high success rates. However, high capital investments on drug discovery process, and stringent government regulations, are some factors expected to restrain antibody services market over the forecast period.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/632

COVID-19 Impact Analysis  

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants  continue to cause concerns and impact normal routines

Antibody Development Segment Revenue to Expand at a Rapid CAGR:

Antibody development segment is expected to register a rapid revenue CAGR over the forecast period attributed to rising R&D expenditure of biotechnology companies, increasing demand for protein therapeutics, large scale adoption of targeted immunotherapy, and favorable government policies on therapeutic antibodies.

BioScience Companies Segment to Register Significant Revenue Growth:

BioScience companies segment is expected to register significant revenue growth over the forecast period due to rising government funding for medical research, increasing focus on drug development procedures to develop new and effective vaccines (especially, during Covid 19 pandemic) and rapid development in healthcare infrastructure.

North America to Account for Largest Revenue Share:

North America is expected to account for largest revenue share in the global market over the forecast period due to rapid development in research infrastructure, presence of biotech and pharmaceutical companies, and increasing government and private investments on drug discovery services. Further, increasing prevalence of infectious diseases and growing number of biotech firms are some other factors expected to contribute to market growth in the region.

Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/632

Major Companies in the Market Include:

  • GE Healthcare
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • Merck KGaA
  • Pall Corporation
  • Sigma-Aldrich Corporation
  • Eppendorf AG
  • Cellab GmbH
  • INTEGRA Biosciences AG
  • FiberCell Systems Inc.

For the purpose of this report, Emergen Research has segmented the global antibody services market based on service, type, end-use, and region:

Service Outlook (Revenue, USD Billion; 2018–2028)

  • Antibody Development
    • Antigen Preparation
    • Immunization & Hybridoma Production
  • Antibody Characterization
  • Antibody Production & Purification
  • Antibody Fragmentation & Labeling

 Type Outlook (Revenue, USD Billion; 2018–2028)

  • Monoclonal
  • Polyclonal

End-Use Outlook (Revenue, USD Billion; 2018–2028)

  • BioScience Companies
  • BioScience Research Institutions
  • Hospitals
  • Others

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/antibody-services-market

Regional Outlook (Revenue, USD Billion; 2018–2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Explore More Reports offered by Emergen Research:

The global metaverse market size reached USD 47.69 Billion in 2020 and is expected to register a revenue CAGR of 43.3% during the forecast period. Rising focus on converging digital and physical worlds using the Internet, increasing traction and popularity of Mixed Reality (MR), and the COVID-19 outbreak and pandemic and subsequent developments and outcomes of the situation are among other major factors expected to continue to drive global metaverse market revenue growth.

The global airborne Intelligence, Surveillance and Reconnaissance (ISR) market size reached USD 9.53 Billion in 2020 and is expected to register a revenue CAGR of 6.4% during the forecast period. Rising demand for Unmanned Aerial Vehicles (UAVs), increasing number of terrorist attack and threats, increasing integration of Artificial Intelligence (AI) and robotics with reconnaissance systems, and rising focus on advancing reconnaissance systems are some major factors expected to continue to drive market revenue growth.

The global optical communication and networking equipment market size reached USD 17.95 Billion in 2020 and is expected to register a revenue CAGR of 8.4% during the forecast period. Market revenue growth is primarily driven by rising number of internet users, penetration of smartphones, and high demand for network connected devices.

The global hypersonic technology market size reached USD 6.30 Billion in 2020 and is expected to register a revenue CAGR of 9.9% during the forecast period. Increase in geopolitical tensions around the world, rising government expenditure in state-of-art defense technologies, and increasing number of public-private partnerships for developing hypersonic technologies are some key factors expected to continue to drive market revenue growth over the forecast period.

The global Virtual Reality (VR) in medical market size is expected to reach USD 3,975.0 Million in 2028, and register a revenue CAGR of 31.1% during the forecast period. Virtual Reality (VR) is gaining significant traction for use in medical marketing. Various medical companies are making substantial investments in VR as a marketing tool to promote their products.

The global wireless brain sensor market size has reached USD 391.7 Million in 2020 and is expected to register a revenue CAGR of 9.5% during the forecast period. Increasing incidence of Traumatic Brain Injuries (TBIs) is resulting in high demand for wireless brain sensors, which is a major factor expected to drive market revenue growth over the forecast period.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Full Press Release@ https://www.emergenresearch.com/press-release/global-antibody-services-market

Back to news